Endovascular Treatment of Dural Carotid Cavernous Sinus Fistulas

Wakhloo, Ajay K.

doi:10.1097/wno.0b013e31819d5669

Cited by 5 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There have been several reports of adverse events specific to the use of NBCA, such as catheter adherence to the vessel wall resulting in catheter rupture 18,23) , NBCA fragment dispersion during catheter withdrawal and consequent non-target embolization 18) , and non-target vessel embolization due to the unexpected peripheral spread of the NBCA or central overflow from the tip of the infusion catheter 18,24,25) . However, to the best of our knowledge, these reports only highlighted a few adverse events of NBCA and rarely indicated their frequency.…”

Section: Discussionmentioning

confidence: 99%

Prospective Evaluation of the Safety and Feasibility of N-Butyl Cyanoacrylate Embolization

Hamaguchi

Ogawa

Wada

et al. 2023

J St. Marianna Univ

View full text Add to dashboard Cite

Several studies have reported the benefits of embolization with N-butyl cyanoacrylate (NBCA); however, few of them have been prospectively studied. This study aimed to prospectively evaluate the safety and feasibility of NBCA embolization, including cases of coagulopathy and/or unstable hemodynamics. Materials and Methods:This study involved a sample of 20 cases treated with NBCA embolization. Cases were excluded from the study if other embolic substances were considered more suitable, if NBCA embolization was utilized for cerebral and coronary vessels, or if the operators determined that NBCA use was unsuitable. Results: There were no cases of severe adverse events specific to NBCA and embolization was successful in all cases. Conclusion: NBCA embolization is a safe and feasible treatment option, even for cases of coagulopathy and/or unstable hemodynamics.

show abstract

Section: Discussionmentioning

confidence: 99%